Printer Friendly

WALTER BRANDES JOINS ZYNAXIS AS VICE PRESIDENT OF SALES AND MARKETING

WALTER BRANDES JOINS ZYNAXIS AS VICE PRESIDENT OF SALES AND MARKETING
 MALVERN, Pa., Oct. 14 /PRNewswire/ -- Zynaxis, Inc. (NASDAQ: ZNXS) today announced that Walter Brandes has joined the company as vice president of sales and marketing for the Diagnostic Division. Mr. Brandes joins the company from Coulter Corporation where he was marketing director for the Cytometry business unit.
 Mr. Brandes has over 17 years of marketing experience including five years with Abbott Laboratories as marketing manager-instrument systems, diagnostic division, and four years with Becton Dickenson & Company as group product manager within the company's immunodiagnostics and automated immunochemistry divisions. Prior to joining Coulter in 1990, Mr. Brandes was the worldwide marketing director for Serono Diagnostics which is a division of Ares-Serono Group, Inc., based in Boston.
 Thomas Cekoric Jr., president and CEO of Zynaxis, stated: "We are extremely pleased to have Walter Brandes on board. We have no doubt that he will be a valuable addition to our team. His first responsibility at Zynaxis will be to coordinate the sales and marketing activities pursuant to our CD4/CD8 AIDS monitoring product which we anticipate having ready for distribution in early 1993. Walter's experience in this area is a tremendous benefit to us."
 Zynaxis, Inc. is a biotechnology company engaged in the development of new therapeutic drug delivery systems and an advanced cellular diagnostic systems.
 -0- 10/14/92
 /CONTACT: Thomas Cekoric Jr., president and CEO of Zynaxis, Inc., 215-889-2200, or Susan Sherman of Cameron Associates, 212-644-9560, for Zynaxis, Inc./
 (ZNXS) CO: Zynaxis, Inc. ST: Pennsylvania IN: MTC SU: PER


CK-EE -- NY025 -- 9762 10/14/92 10:24 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 14, 1992
Words:267
Previous Article:CENTERCORE TO FORM AIRTEK DIVISION; UNIT WILL SUPPORT EXPANDING AIRFLOW PRODUCT LINES
Next Article:VINTAGE PETROLEUM ANNOUNCES WELL COMPLETION
Topics:


Related Articles
ZYNAXIS, INC. COMPLETES PUBLIC OFFERING OF 2.5 MILLION SHARES
OVER-ALLOTMENT OPTION EXERCISED IN ZYNAXIS PUBLIC OFFERING
MICHAEL CHRISTIE, PH.D. JOINS ZYNAXIS AS VICE PRESIDENT OF PROCESS DEVELOPMENT
ZYNAXIS APPOINTS KEITH MANSFORD, PH.D. TO BOARD OF DIRECTORS
ZYNAXIS APPOINTS ALAN STEIGROD TO BOARD OF DIRECTORS
ZYNAXIS ANNOUNCES PROMOTION OF DR. MUIRHEAD AND RESCHEDULES DIAGNOSTIC PRODUCT CLINICALS
ZYNAXIS APPOINTS MARTYN GREENACRE PRESIDENT AND CEO
MARTYN GREENACRE ASSUMES CHAIRMAN OF THE BOARD POSITION OF ZYNAXIS
ZYNAXIS AND SECRETECH ANNOUNCE MERGER PLANS; FOCUS ON DRUG DELIVERY STRENGTHENED
MARKETING PEOPLE.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters